Berry Genomics Hits Day High with 10.02% Surge in Strong Intraday Performance

Berry Genomics Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a significant uptick in its stock price, gaining 10.02% on August 10, 2026. The stock reached an intraday high of CNY 9.99, marking a notable moment in its trading activity. Over the past week, Berry Genomics has shown a robust performance with an 18.93% increase, significantly outpacing the China Shanghai Composite, which rose by only 4.12% during the same period. In the last month, the stock has surged by 27.59%, while the broader index has faced a slight decline of 0.74%. Despite these recent gains, Berry Genomics has faced challenges over the longer term, with a one-year performance down by 32.45% and a five-year decline of 63.26%. The company has struggled with profitability, reflected in a low Return on Capital Employed (ROCE) of 1.32% and a concerning trend of negative growth in net sales and operating profit over the past five years. As Berry Genomics continues to navigate its market position, today's performance highlights a moment of activity amid a backdrop of longer-term challenges.